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Abstract
A transmembrane (TM) single-polypeptide-chain (sc) linker can connect two G-protein–
coupled receptors (GPCRs) in tandem. The priority of a gene-fusion strategy for any two 
class A GPCRs has been demonstrated. In the striatal function, dopamine (DA) plays 
a critical role. In the striatum, how the GPCR for adenosine, subtype A
2A
 (A
2A
R), con-
tributes to the DA neurotransmission in the “volume transmission”/dual-transmission 
model has been studied extensively. In addition to the fusion receptor, i.e., the prototype 
scA
2A
R/D
2
R complex (the GPCR for DA, subtype D
2
), several types were created and 
tested experimentally. To further elucidate this in vivo, we designed a new molecular 
tool, namely, the supermolecule scA
2A
R/D
2
R. Here, no experiments on its expression 
were done. However, the TM linker to connect the nonobligate dimer as the transient 
class A GPCR nanocluster that has not been identified at the cell surface membrane 
deserves discussion through scA
2A
R/D
2
R. Supramolecular designs, are experimentally 
testable and will be used to confirm in vivo the functions of the two GPCRs interactive in 
such a low specific signal to the nonspecific noise (S/N) ratio in the neurotransmission in 
the brain. The sc also has, at last, become straightforward in the field of GPCRs, similar 
to in the field of antibody.
Keywords: oligomerization, adenosine A
2A
 receptor, dopamine D
2
 receptor, receptor 
allostery, fusion protein, striatum, supramolecular protein assembly
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1. Introduction
Dopamine (DA) [1] plays a critical part in the function in the striatum of the basal ganglia [2, 3]. 
In striatal DA neurotransmission, how the G-protein–coupled receptor (GPCR) for adenosine, 
subtype A
2A
 (A
2A
R) [4, 5], works in the “volume transmission”/dual-transmission model [6] 
was explored previously [7, 8]. Moreover, the prototype single-polypeptide-chain (sc) het-
erodimeric A
2A
R/D
2
R complex (the GPCR for DA, subtype D
2
 [9]) [10] (Figures 1–3), a fusion 
receptor, and several other types were created and tested experimentally [11]. Supermolecules 
were also designed, none of which were constructed or tested [12], while referring to a relation-
ship between nanoscale surface curvature and surface-bound protein oligomerization [13–15]. 
Here, the transmembrane (TM) linker to connect the nonobligate dimer will be discussed based 
on scA
2A
R/D
2
R.
2. Making the single-polypeptide-chain to compensate the weak 
affinity of the two molecules
2.1. Glycine-glycine-glycine-glycine-serine (G
4
S) linker
Approximately 30 years ago, a 15–amino acid linker [glycine-glycine-glycine-glycine-ser-
ine (G
4
S)
3
] was adopted to form a variable region fragment (Fv) analogue connected as a 
Figure 1. A transmembrane single-polypeptide-chain (sc) linker to connect two G-protein–coupled receptors in tandem. 
See text for details.
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single polypeptide chain (single-chain Fv), consisting of the heavy- and light-chain vari-
able regions (VH and VL) of a monoclonal antibody (mAb). This was successfully produced 
in Escherichia coli or bacteriophage by protein engineering based on the crystallographic 
analysis of the antigen-binding fragments (Fabs) of antibodies, i.e., the carboxy-terminus 
Figure 2. A supermolecule of an `exclusive´ dimeric GPCR with the oil-fence–like structure. (A) Using the light-harvesting 
antenna complex from Thermochromatium tepidum, the C-ter of an α-apoprotein (Angle 1 in B, in dotted line in gray) of two 
(Angles 1 and 16), each of which is concatenated in tandem through a CD4 transmembrane (TM) region in purple (in darker 
gray for a printed version in black and white) between Angles 1 and 16; CD4 is well known to make no formation of dimer 
itself, fused to the N-ter of TM helix 1 of the human prototype scA2AR/D2LR, i.e., A2AR-odr4TM-D2LR colored (in the same gray 
as in Figure 1 for a printed version in black and white), and its C-ter of TM helix 7 fused to the N-ter of another α-apoprotein 
(Angle 8) of other two (Angles 8 and 9 here in B, as given angles of the complex, in dotted line in gray), i.e., the α-apoprotein-
CD4TM-α-apoprotein-scGPCR-α-apoprotein-CD4TM-α-apoprotein fusion, is shown. Its expression as a fusion with 
the remaining ~12 α-apoproteins (presumed to be 16 mer originally in total), i.e., four 3mers (Angles 2–4, 5–7, 10–12, and 
13–15 in B) of α-apoprotein fused to a motif sequence driving α-helical coiled coil interaction as lines in blue (in darker 
gray for a printed version in black and white) on the left in B because four 4mers and eight 2mers cannot exclude vacant 
supermolecules, could form a unified complex, with ~16 wild-type β-apoproteins (plus the translation initiation methionine) 
in total and pigments, thus surrounding scA2AR/D2LR. (B) The light-harvesting antenna complex (LH1, a gray circle) from 
Thermochromatium tepidum consists of 16 mer of the α-apoprotein [61 amino acids, with the intracellular N-terminus (N-ter); 
for clarity, instead of a hexadecagon (not shown here) with each angle numbered, some are shown as a nonagon] packed side 
by side to form a hollow cylinder of diameter 73–82 Å and the 16 helical β-apoproteins (46 amino acids plus the translation 
initiation methionine, with the intracellular N-ter) of an outer cylinder of diameter 96–105 Å, together with light-absorbing 
pigments (not shown here) 32 bacteriochlorophyll a (Bchl a) and 16 carotenoids (spirilloxanthin, Spx) [77]. Lines of 72 Å are 
shown in black. The figure art (A) is shown and was drawn and adapted from the published figure, i.e., the figure art (lower 
left) for A2AR-odr4TM-D2LR in Fig. 1A (pp. 140), in our previous report [10], with written permission of the copyright owner, the Japan Society for Cell Biology. Only small but biologically important modifications were introduced.
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(C-ter) of the V
H
 domain and the amino-terminus (N-ter) of the V
L
 domain, being at a dis-
tance of ≈3.5 nm [16, 17]. The use of a spacer (linker sequence) of ~30 amino acids, including 
G
4
S, between the two proteins was established after that, giving (G
4
S)
3
: 3.5 nm [18]. As a 
compensation for the weak interactions between the two proteins, a tandem is especially 
Figure 3. Transient class A GPCR nanocluster. TM helices (transverse sections) are shown as circles [numbered, in black 
(D
2
R) or white (A
2A
R)]. The A
2A
R and D
2
R ligands are also shown as black and light gray ovals, respectively. odr4TM in 
the scA
2A
R/D
2
R is shown in a gray rectangle. This figure is from the figure art of the graphical abstract in our previous 
report [11], with written permission of the copyright owner, Elsevier Inc.
Polypeptide - New Insight into Drug Discovery and Development44
useful. Under the molecular dynamics and the organizing principles of the plasma mem-
brane [19], depending on the GPCR monomer-dimer dynamic equilibrium that is character-
ized by single-molecule imaging to date [20], the endocytosis of the GPCR is mediated by 
the clathrin-coated pit machinery [21]. The clathrin coats on the endosome vesicles resem-
ble the architecture of a soccer ball, and each clathrin that forms a three-legged structure 
assembles into typical polyhedral cages, with an inscribed or circumscribed circle width 
diameter of approximately 25 nm ([11]: graphical abstract) (Figure 3). At issue are the tun-
ing and amplitude of GPCR oligomerization. Using a β2V2R receptor chimera [the class 
A GPCR β
2
 adrenergic receptor where the C-ter tail was exchanged for the class B GPCR 
vasopressin type 2 receptor (V2R) C-ter] [22], the existence, functionality, and architecture 
of internalized class B GPCR complexes, called supercomplexes or “megaplexes,” result-
ing in sustained signaling, are reported to consist of a single GPCR, β-arrestin, and G pro-
tein. Additionally, GPCR-mediated extracellular signal-regulated kinase (ERK) activation 
is classified into two modes, including an early, β-arrestin–independent one, which may 
correspond to nanocluster activation at the cell surface membrane, and a late, β-arrestin–
dependent one, which prolongs ERK activity. Nanoclusters are transient dynamic struc-
tures that are assembled by the lipid-anchored proteins [23]. With regard to Ras proteins, 
they are arrayed in nanoclusters comprising 6–8 proteins in domains that are 12–22 nm in 
diameter. However, the transient class A GPCR nanocluster has not been identified at the 
cell surface membrane.
2.2. Glycine-threonine (GT) linker
In a report by Twomey et al., in order to form the complex between the α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid-subtype ionotropic glutamate receptor GluA2 and the aux-
iliary protein stargazin (STZ), they used “a tandem construct, GluA2-STZ, where the N-ter of 
STZ was fused to the C-ter of GluA2 by a glycine-threonine (GT) linker.”{[24]—(pp. 83, the 
right column—the second paragraph—line 1)}.
2.3. Glycine-serine-anchored 6– or 30–amino acid (GSxxGS) linker
In a report by Elegheert et al., they used the fusion protein of the Cbln1C1q-GluD2ATD. Cbln1 is a soluble synaptic organizer molecule with a compact jelly-roll β-sandwich fold and 
is a member of complement C1q-tumor necrosis factor superfamily that directly binds 
the ionotropic glutamate receptor δ2 extracellular N-ter domain GluD2 ATD. Cbln1 also 
interacts with presynaptic membrane-tethered neurexins that, with postsynaptic neuroli-
gins, make up the transsynaptic bridges spanning the synaptic cleft [25]. Because of the 
weak affinity of the Cbln1C1q-GluD2ATD interaction, they designed a construct that “linked 
a Cbln1C1q trimer with GluD2ATD into one continuous polypeptide chain by using short six-amino acid linkers (GSELGS and GSASGS in single-letter amino acid code, respec-
tively)” and “by a 30-residue flexible Gly-Gly-Ser ((G
2
S)
10
) spacer, which may reach ~110 
Å in length in a fully extended conformation and would allow quasi-unrestricted confor-
mational sampling of the GluD2
ATD
 by Cbln1C1q-fused during the crystallization process.” 
([25]—supplementary text).
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2.4. Transmembrane linker
Levitz et al. took advantage of a gene-fusion strategy used previously for microbial opsins [26] 
to construct a tandem dimer, where a TM linker connects the C-ter of the first copy of a class C 
GPCR, the metabotropic glutamate receptor mGluR2, to the N-ter of a second [27]. The gene-
fusion strategy of Kleinlogel et al. proved to be useful in optogenetics and for any two class 
A GPCR rhodopsins, using “the light-activated microbial rhodopsins”: Channelrhodopsin-2 
(ChR2) derived from Chlamydomonas reinhardtii [“a cation-permeable channel that enables cell 
depolarization (neuronal activation) in response to blue light”] and halorhodopsin derived 
from Natromonas pharaonis (NphR or Halo) [“a chloride pump that enables cell hyperpolar-
ization (neuronal silencing) in response to orange light”] [26], i.e., the intracellular C-ter of 
ChR2 through β helix (the 105-amino-acid N-ter fragment of the β subunit of the rat gastric 
H+,K+-ATPase) fused to the extracellular N-ter of NphR for the “precise co-localization and 
stoichiometric expression of two different light-gated membrane proteins.” However, they 
found that in the fusion of ChR2(1-309) with βbR (a variant of the inhibitory proton pump 
bacteriorhodopsin from Halobacterium salinarum, containing an additional N-ter TM β helix), 
the insertion of an enhanced yellow fluorescent protein (EYFP) between the two proteins 
resulted in its functional expression (ChR2-EYFP-βbR). However, they did not try another β 
helix itself, the effects of their length, or the reverse type (such as bR-EYFP-βChR2), unlike the 
TM α helix linkers in our previous report [11]. Interestingly, rational de novo computational 
protein design of the α-helical domain is also reported [28–30].
The points raised in our study about how the A
2A
R contributes to the DA neurotransmission 
are addressed in a straightforward manner (Figure 1) (Section 3.1). Thus, making the sin-
gle-polypeptide-chain has also, at last, become straightforward and is no longer an unusual 
approach to stimulate the weak affinity of two molecules in the field of neuroscience/GPCR, 
similar to in the field of immunology/monoclonal antibody. Additionally, “the glycan wedge” 
approach by “a 10-residue glycosylated linker” (ELSNGTDGAS in single-letter amino acid 
code) arranged between the ATD and ligand-binding domain (LBD) layers “in order to space 
them apart and disrupt potential mechanical ATD-LBD coupling” [25] is shown to function 
in inhibiting the association between protomers of the γ-aminobutyric acid (GABA) type B 
receptor (GABAB)[GABAB1 (GB1)]/[GABAB2 (GB2)] heterodimer (via coiled-coil interaction of the cytoplasmic C-ter) but not that of the tetramer (GB2/GB1)-(GB1/GB2) [31].
Furthermore, the DA neurotransmission in the “volume transmission”/dual-transmission 
model could not physically adopt the supramolecular architectures, such as “the prototypi-
cal molecular bridge linking” postsynaptic GluD2 and the presynaptic neurexin, via Cbln1, 
besides a possible link between the glial A
2A
Rs and presynaptic or postsynaptic D
2
R.
2.5. An enzyme-dependent covalent biotinylation occurs within 10–50 nm of the bait 
protein
BioID is an affinity purification approach where an E. coli BirA biotin-protein ligase, 
BirAR118G (BirA, with Gly replacing Arg 118), is fused to a bait protein expressed in cells 
and allows for the isolation and analysis of proximal proteins by streptavidin-based affinity 
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purification and mass spectrometry [32–36]. “Biotinylation by BioID is a mark of proxim-
ity and not evidence for physical interaction,” and causing “the practical labeling radius of 
BioID in vivo to be ~10 nm” [32]. Thus, similar to the proximity ligation assay (PLA), BioID is 
a “proximity assay that may detect adjacent proteins that are not true interactor” [36]. Across 
the cell surface membrane, BirA-dependent covalent biotinylation cannot occur even within 
10–50 nm of the bait protein.
3. The transmembrane-linked connection of the nonobligate dimer: 
scA
2A
R/D
2
R
3.1. An approach toward a class A GPCR dimer that is not fully formed
With a model of receptor-receptor interaction to regulate DAergic activity, a functional antag-
onistic interaction between A2AR and D2R has been explicated [37–40]. Although allostery in 
a GPCR heterodimer is demonstrated [41–45], these class A GPCR dimers, unlike other class 
GPCRs that are fully formed [46], depend on the equilibrium between monomers and dimers 
[47]. This does not mean that such insufficient class A GPCR dimers or oligomers cannot func-
tion in vivo. Some types of protein-protein interactions, transient or weaker, “will be found to 
play an even more important role” in the cells [48, 49].
Interestingly, in the process of rational design and screening, we found that fusion of the 
two receptors stimulates the receptor dimer formation [10, 11]. In these studies, by fusing 
the cytoplasmic C-ter of the human brain–type A2AR (that is derived from Dr. Shine’s cDNA 
[50]) ([12]: Fig. S1) through the TM domain of a type II TM protein (Section 4.3) with the 
extracellular N-ter of D2R in tandem, we made successful designs for a fusion receptor, single-
polypeptide-chain (sc) heterodimeric GPCR complex A2AR/D2R [10, 11]. However, the result-
ing prototype scA2AR/D2LR (D2LR, the long form of D2R) has a compact folding, i.e., a fixed 
stoichiometry (the apparent ratios of A2AR to D2R binding sites), A2AR:D2R = 10:3 = 3–4:1 ([11]: 
graphical abstract) (Figure 3), and the scA2AR/D2R expression system shows that the various 
designed types of functional A2AR/D2R exist even in living cells, but there is no apparent allo-
stery as a whole. Thus, to further clarify the heteromerization through scA2AR/D2LR, we tried 
to design other fusion proteins so as not to be formed/expressed as higher-order-oligomers, 
and we called these ‘exclusive’ monomers or dimers. First, we noted that GPCRs have general 
features of a TM helix 3 as the structural [at a tilt-angle of 35° to a perpendicular (vertical) 
line to the cell surface membrane plane]/functional hub and a TM helix 6 moving along 14 Å 
after activation [51] and of A2AR, with a bundle width diameter of approximately 3.6 nm [12]. 
Thus, using a partner to increase spacing [25] without identifying and specifically blocking 
the interacting portions between the receptors, we created the designs for nonoligomerized 
‘exclusive’ monomeric A2AR and/or D2R in order to exclude their dimer/oligomer formation 
[12] (Sections 4.1.1 and 4.1.2), and did those for the ‘exclusive’ dimer [12] [Fig. 2, (Section 4.2)]. 
Such a self-assembled molecular architecture will entirely hold either a monomeric receptor 
or single dimeric A2AR/D2R alone, but none of the oligomers. Although we constructed or tested none of these new fusions, we aimed to obtain heterodimer-specific agents using the 
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fusion receptor scA2AR/D2R. Indeed, we can take an example of a universal influenza vaccine 
that was engineered by fusing two polypeptides. The polypeptides originally resulted from 
the limited proteolysis of the native conformation of the hemagglutinin (HA), a trimeric mem-
brane protein of influenza viruses, and their conformations were retained and stabilized in 
the vaccine engineering [52]. Such ‘exclusive’ forms of single-chain dimers are useful analyti-
cal tools, allowing us to address this point. Additionally, in the postsynaptic striatopallidal 
γ-aminobutyric acid (GABA)-ergic medium spiny projection neurons (the indirect pathway), 
expressing both A2AR and D2R, an in vivo analysis of knock-in mice of the scA2AR/D2R would 
elucidate the functional A2AR/D2R with the antagonism [12], thus, to confirm us, in vivo, that such a low S/N ratio interaction between A2AR and D2LR functions in the DA neurotransmis-
sion in the striatum.
The heterodimeric interaction of A2AR with D2R depends, in part, on the cytoplasmic C-ter 
region of A2AR [53]. Although the three-dimensional (3D) structures of the GPCR heterodi-
mer also remains unresolved crystallographically [39], a possible monovalent agent acting on 
GPCR heterodimers was made reference to, and a screen needs developing to this end [54]. 
Our goal is to prove that the above-mentioned scGPCR-based screen is such a system. Here, 
we aim to obtain such heterodimer-specific agents [12], using a supramolecularly [55–57] 
designed fusion receptor, scA2AR/D2R, i.e., nonoligomerized ‘exclusive’ monomer (Section 
4.1) and dimer (Section 4.2) of the receptors, and the above-mentioned in vivo analysis of the 
functional antagonistic A2AR/D2R. The possible occurrence of an unsuitable folding into a 3D 
structure, such that the resulting receptor exhibits lower or false activity, should be avoided. 
This is attributed to the interaction between a single ‘exclusive’ form of either the receptor 
monomer or scA2AR/D2R and the surrounding fence-like architecture, while considering a 
single bond between two carbon atoms, with a C─C covalent bond with a distance of 1.5 Å 
(Section 4.3).
3.2. The molecular populations of the A
2A
R/D
2L
R species in cell membranes
To illustrate this point, for clarity, let us consider epitopes generated only in heterodi-
meric A2AR/D2LR, but not in monomeric (and/or homodimeric) A2AR or D2LR [11] (Figure 1), which is in accordance with findings on the existence of agonistic/antagonistic (active/
inactive-state-specific) or dimer-specific antibodies (nanobody) ([12]: Table 1). A broad and 
extremely potent human immunodeficiency virus (HIV)-specific mAb, termed 35O22, is 
reported, which binds the gp41−gp120 interface of the viral envelope glycoprotein (trimer 
of gp41–gp120 heterodimers) [58] ([12]: Table 1). This dimer-specific mAb was obtained 
despite not being immunized. The existence of virus-neutralizing mAbs, such as 35O22, 
which recognizes HIV-1 gp41–gp120 interface [58], and 2D22, locking the dimeric envelope 
proteins of dengue virus type 2 [59], is suggestive of that of the heterodimer-specific mAb 
that we are interested in. Additionally, transient nucleotide-bound β2-Gs species that are 
distinct from known structures are revealed [60]. Thus, the expression of homogeneous 
molecular species, either monomer or dimer, but not the mixture of both, followed by their 
membrane preparation appropriate to our needs, is necessary and worthy to be addressed 
experimentally.
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4. Architecture of a transmembrane-linked scA
2A
R/D
2
R
4.1. Supramolecular monomer
4.1.1. Protein assembly regulation and ‘exclusive’ monomers, supramolecularly designed using 
the Cε2 domain of IgE-Fc: the scA2AR/D2R-transmembrane linker makes both receptors stay away from each other
The molecular entity of the allosteric modulation of A2AR/D2R remains unresolved. To solve the insufficiency of the dimer formation of A2AR/D2LR, various scA2AR/D2R constructs, with 
spacers between the two receptors, were created (Figure 3). Successful designs of fusions, 
A2AR-D2R(ΔTM1) (not shown), D2R-A2AR(ΔTM1) (Figure 1), the prototype A2AR-odr4TM-
D2R, fusions, which have the same configuration as the prototype, but with different spac-ers, and the same configuration as the prototype, but with different TM (A2AR-TM-D2R), and the reverse configuration, D2R-odr4TM-A2AR, were designed. Using whole cell binding 
assays, the constructs were examined for their binding activity. Two papers [61, 62] inspired 
us to also design the following fusions ([12]: Fig. 1B): first, the conversion between a single- 
and two-antigen binding brought by using a hinge/domain in the designed antibody was 
reported. Then, in models of viral fusogenic proteins, both steric hindrance and conforma-
tional changes, i.e., negative cooperativity, were referred to. Accordingly, we took advantage 
of the structure of the complete Fc fragment (Fc) of immunoglobulin (Ig) E, including the Cε2 
domains, which is a compact, bent conformation ([63]: pp. 205, the right column-line 2 from 
the bottom; [64]) (the human IgE has a rigid Cε2 domain of Fc portion, instead of lacking a 
flexible hinge region, in contrast to other class/subclasses, such as IgG1. Upon binding of an 
allergen to the IgE that is already bound to the high-affinity receptor FcεRI, the antigen bind-
ing fragment (Fab) portion transduces it to the FcεRI [64]). Thus, the expression of the ‘exclu-
sive’ monomeric GPCRs linked with the transmembrane plus human Cε2 domain (here in a 
loop), i.e., the C-ter of the odr4TM of the prototype scA2AR/D2LR fused to the N-ter of Cε2 and its C-ter fused to the N-ter of the D2LR, could separate from each other. Whereas the prototype 
A2AR-odr4TM-D2R stimulates the dimerization of A2AR and D2R, this type of Cε2-intervening 
scA2AR/D2R makes both receptors push out each other, resulting in two ‘exclusive’ mono-mers. To this end, additional bulky molecules at both the N-ter and the C-ter of the fusion 
would be required.
4.1.2. Another `exclusive´ monomeric GPCR with the oil-fence–like structure: a supermolecule 
using transmembrane apoproteins from a bacterial light-harvesting antenna complex
The human A2AR structure PDB 3EML [12] has a bundle width diameter of approximately 
36 Å. It was determined by the T4-lysozyme fusion strategy [65], where most of the intracel-
lular loop 3 (Leu2095.70–Ala2216.23: the Ballesteros-Weinstein numbering scheme is shown in 
superscript) [66] was replaced with a lysozyme from T4 bacteriophage, and the C-ter tail 
(Ala317–Ser412) was deleted to improve the likelihood of crystallization. According to recent 
papers, ‘the most complex designed membrane proteins contain porphyrins that catalyze 
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transmembrane electron transfer’ [55]. The peripheral light-harvesting antenna complex 
(LH2) [12] derived from the purple bacterium Rhodopseudomonas acidophila (Rhodoblastus aci-
dophilus) strain 10050 is made up of both a 9 mer of the transmembrane α-apoprotein (53 
amino acids, with the intracellular N-ter) grouped side by side to form a hollow cylinder with 
a radius of 18 Å and the 9 transmembrane helical β-apoproteins (41 amino acids, with the 
intracellular N-ter) of an outer cylinder with a radius of 34 Å, together with porphyrin-like, 
light-absorbing pigments bacteriochlorophyll a (Bchl a) and carotenoids [67]. Thus, a com-
plex could be formed as an `exclusive´ monomeric GPCR with the oil-fence–like structure, by 
expressing both the C-ter of this α-apoprotein fused to the N-ter of TM helix 1 of GPCR, plus 
the C-ter of the TM helix 7 fused to the N-ter of another α-apoprotein, and other 7 wild-type 
α-apoproteins, together with 9 β-apoproteins and pigments [12].
4.2. An `exclusive´ dimeric GPCR with the oil-fence–like structure: a supramolecular 
dimer
Using the LH complex from Thermochromatium tepidum, the C-ter of the second copy (Figure 2: 
Angle 1 in B, in dotted line in gray) of two α-apoproteins (Angles 1 and 16), each of which 
is concatenated in tandem through the human leukocyte antigen (cluster of differentia-
tion, CD) CD4 TM region (in purple between Angles 1 and 16; CD4 is well known to make 
no formation of a dimer itself), fused to the N-ter of TM helix 1 of the human prototype 
scA
2A
R/D
2L
R, i.e., A
2A
R-odr4TM-D
2L
R (colored), and its C-ter of TM helix 7 fused to the N-ter 
of another α-apoprotein (Angle 8) of the other two (Angles 8 and 9 herein in B, as given 
Angles of the complex, in dotted line in gray), i.e., the α-apoprotein-CD4TM-α-apoprotein-
scGPCR-α-apoprotein-CD4TM-α-apoprotein fusion, is shown. Its expression as a fusion, with 
the remaining ~12 α-apoproteins (presumed to be 16 mer originally in total), i.e., four 3mers 
(Angles 2–4, 5–7, 10–12, and 13–15 in B) of α-apoprotein fused to a motif sequence driving 
α-helical coiled coil interaction (as blue lines on the left in B) because four 4mers and eight 
2mers cannot exclude vacant supermolecules, could form a unified complex, with ~16 wild-
type β-apoproteins (plus the translation initiation methionine) in total and pigments, thus 
surrounding scA
2A
R/D
2L
R.
4.3. Predicting the interaction between the TM linker, odr4TM, in prototype scA
2A
R/
D
2
R and TMs of its surrounding (fence-like) LH proteins
Protein-protein interactions can be classified on the basis of their binding affinities [48, 49, 
68, 69]: by definition, unlike permanent interactions with high affinities (K
d
 in the nM range), 
proteins interacting transiently, either weakly or strongly, show a fast bound-unbound equi-
librium, with K
d
 values typically in the μM range or less. In our previous reports [10, 11], 
among the GPCR protein-protein interactions, such as the disulfide bond formation of the 
N-ter, coiled-coil interaction of the cytoplasmic C-ter, and TM interaction [70], a type II TM 
protein with a cytoplasmic N-ter segment, single TM, and extracellular C-ter tail, i.e., the 
Caenorhabditis elegans accessory protein of odorant receptor (odr4) [71], was first selected for 
a connection between the N-ter receptor half (A
2A
R) and the C-ter receptor half (D
2L
R) of the 
scA
2A
R/D
2L
R. Then, it was demonstrated that the insertion of some other TM sequence, instead 
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of the odr4TM sequence, works similarly or that it does not have to be odr4TM to work, using 
the scA
2A
R/D
2L
R designed with another TM of a type II TM protein, the human low-affinity 
receptor for IgE designated CD23 (Section 3.1).
Among the Smart blast search of odr4TM hits, a hit of a photosynthetic protein [of photo-
system (PS) II reaction center (RC)] is impressive to us because of the use of its surrounding 
apoproteins in the bacterial LH complex in the supramolecularly designed scA
2A
R/D
2
R, as 
described above [12]. The Blastp search of the odr4TM against all nonredundant GenBank 
databases and the human genome gave no hits for human CD23.
On the other hand, CD23 is highly conserved among mammals. The Smart blast search sug-
gests that human CD23TM is selected as a preferable experimental design due to little rela-
tionship between the two protein TMs.
In photosynthesis, certain protein complexes, such as the PS (or the LH1 and the RC), build 
the highly efficient, light-induced charge separation across the membrane, followed by elec-
tron transport. More strictly, PSI forms supercomplexes with the RC and the light-harvest-
ing proteins, i.e., PSI-type RC and LHCI, and PSII supercomplexes are PSII-type RC, core 
light-harvesting proteins (CP43 and CP47), and peripheral LHCII in aerobic photosynthesis 
(algae, cyanobacteria, and plants); PS is a type RC, core LH1, and peripheral LH2 in anaero-
bic photosynthesis (purple bacteria). Whether this quality of photosynthetic light reactions 
is negligible or not in our ‘exclusive’ supramolecular forms has not been tested. The rear-
rangement of each molecule in this architecture or exchange with similar but unrelated 
molecules [72] would be necessary to inhibit this completely and surround the prototype 
scA
2A
R/D
2
R.
In a recent report on PSII biogenesis, it is shown that, unlike its cyanobacterial counterpart, 
the PSII RC protein D1 C-terminal processing enzyme of a land plant Arabidopsis is essential 
for assembling functional PSII core complexes, dimers, and PSII supercomplexes [73], demon-
strating a discrepancy in PSII protein assembly [72] between cyanobacterium and Arabidopsis. 
Thus, whether the LH is attached and expressed to form our supermolecules in animal cells 
requires testing. The D1 and D2 subunits of the PSII and the M and L subunits of the bacterial 
photosynthetic RC are members of the Photo RC (cl08220) protein superfamily. However, 
these proteins differ in their number of TM helices [12, 74–77]. In addition, for the follow-
ing three reasons, it is persuasive to predict the interaction between odr4TM in prototype 
scA
2A
R/D
2
R and TMs of its surrounding (fence-like) LH proteins: (1) based on findings that 
the RC affects the LH1 complex shape [78], (2) and that it remains unknown what structural 
features lead to the consequent differences in the nonameric and octameric apoprotein assem-
blies in LH2, respectively, from Rhodopseudomonas acidophila and another purple bacterium, 
Rhodospirillum (Phaeospirillum) molischianum [79], thus meaning that it remains unknown 
why LH1 surrounds the RC but LH2 does not, (3) and furthermore, due to the difficulty in 
membrane-protein topology prediction itself, up to 25% precision, “to predict interaction sites 
from sequence information only” {[80]: supporting information—[Table 9. List of PDB IDs of 
all monomers (Test-set 1)] (pp. 38, line 27), human A
2A
R (PDB: 3EML) ([12]: Fig. 2A) (Section 
3.1.2) defined as a monomer}.
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Thus, as a source of information for the prediction of the protein-protein interactions [81], 
multiple sequence alignments were analyzed between the C. elegans odr4TM or human CD23 
TM and TMs of core RC proteins (L/M/H) of T. tepidum or Rhodopseudomonas (Blastochloris) 
viridis [12]. It indicates no relationship [12], suggesting that the αβ subunits for the LH sur-
rounding scA
2A
R/D
2
R do not affect their core GPCR itself substituted for the core RC, even 
if each protein in this supermolecule is assembled to form it. Whether alternative interac-
tions between core GPCRs and surrounding LH subunits in our supermolecules exist remains 
unknown because our designs are only back-of-envelope sketches and also, 3D-models, espe-
cially of membrane proteins, have their limitations [12, 82–84].
5. Summary and outlook
The supramolecular designs of transmembrane-linked scA
2A
R/D
2L
R, ‘exclusive’ monomers 
and dimers using the Cε2 domain of IgE-Fc or apoproteins of the bacterial light-harvesting 
antenna complex, allowing us to express the class A GPCR by receptor protein assembly regu-
lation, i.e., the selective monomer/nonobligate dimer formation, are experimentally testable 
and will be used to confirm, in vivo, that such low S/N ratio interaction between A
2A
R and 
D
2L
R functions in the dopamine neurotransmission in the striatum.
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